← Back to front page
Asia · Regional markets · CNBC-TV18

Zydus Lifesciences Q2 Results: Shares fall after profit drops 27%, margins contract

Published by CNBC-TV18 · India 1 h ago

The North America formulations business reported revenue of ₹33,145 million, up 21% year-on-year and 7% quarter-on-quarter. Growth was driven by sustained volume expansion in the…

Read the full article on CNBC-TV18 Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.cnbctv18.com)

Also worth reading

Tech in Asia

Databricks opens new office, plans $350m Singapore investment

 Business Standard

BEL stock rises 5% as order inflow optimism keeps MOFSL upbeat post Q2

 The Straits Times Business

Crypto dips on Democrat midterm wins, Binance hacks dent optimism

 Mint

Muhurat Trading Picks: Tata Steel, Coal India to BEL - HDFC Sec recommends these 10 stocks to buy on Diwali | Full list

 The Business Times

Former CEO of SGX-listed GS Holdings charged for false trading

 The Edge Malaysia

CIMB Group Holdings Bhd